tiprankstipranks
Tenet Healthcare (CH:THC1)
:THC1
Switzerland Market

Tenet Healthcare (THC1) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

THC1 Analyst Ratings

Strong Buy
14Ratings
Strong Buy
13 Buy
1 Hold
0 Sell
Based on 14 analysts giving stock ratings to
Tenet
Healthcare
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

THC1 Stock 12 Month Forecast

Average Price Target

Based on 14 Wall Street analysts offering 12 month price targets for Tenet Healthcare in the last 3 months. The average price target is CHF227.37 with a high forecast of CHF248.02 and a low forecast of CHF197.29. The average price target represents a change from the last price of .
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
Highest Price TargetCHF248.02Average Price TargetCHF227.37Lowest Price TargetCHF197.29
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
UBS
CHF248.02
Buy
Reiterated
08/25/26
UBS Reaffirms Their Buy Rating on Tenet Healthcare (THC)
Mizuho Securities Analyst forecast on CH:THC1
Mizuho Securities
Mizuho Securities
CHF201.31CHF233.52
Buy
Reiterated
08/10/26
Tenet Healthcare price target raised to $290 from $250 at MizuhoTenet Healthcare price target raised to $290 from $250 at Mizuho
Bank of America Securities Analyst forecast on CH:THC1
Bank of America Securities
Bank of America Securities
CHF233.52CHF237.55
Buy
Reiterated
08/10/26
Bank of America Securities Sticks to Their Buy Rating for Tenet Healthcare (THC)
Wells Fargo Analyst forecast on CH:THC1
Wells Fargo
Wells Fargo
CHF186.01CHF226.27
Buy
Assigned
07/31/26
Tenet Healthcare price target raised to $281 from $231 at Wells FargoTenet Healthcare price target raised to $281 from $231 at Wells Fargo
Goldman Sachs Analyst forecast on CH:THC1
Goldman Sachs
Goldman Sachs
CHF202.92CHF245.6
Buy
Assigned
07/29/26
Tenet Healthcare price target raised to $305 from $252 at Goldman SachsTenet Healthcare price target raised to $305 from $252 at Goldman Sachs
Truist Financial Analyst forecast on CH:THC1
Truist Financial
Truist Financial
CHF217.42CHF233.52
Buy
Reiterated
07/28/26
Truist Financial Remains a Buy on Tenet Healthcare (THC)
Robert W. Baird Analyst forecast on CH:THC1
Robert W. Baird
Robert W. Baird
CHF169.1CHF225.47
Hold
Reiterated
07/28/26
Tenet Healthcare price target raised to $280 from $210 at BairdTenet Healthcare price target raised to $280 from $210 at Baird
Morgan Stanley Analyst forecast on CH:THC1
Morgan Stanley
Morgan Stanley
CHF204.53CHF220.64
Buy
Reiterated
07/27/26
Tenet Healthcare price target raised to $274 from $254 at Morgan StanleyTenet Healthcare price target raised to $274 from $254 at Morgan Stanley
Guggenheim Analyst forecast on CH:THC1
Guggenheim
Guggenheim
CHF194.87CHF227.88
Buy
Reiterated
07/27/26
Tenet Healthcare price target raised to $283 from $242 at GuggenheimTenet Healthcare price target raised to $283 from $242 at Guggenheim
Stephens
CHF201.31CHF229.49
Buy
Reiterated
07/27/26
Tenet Healthcare price target raised to $285 from $250 at StephensTenet Healthcare price target raised to $285 from $250 at Stephens
TD Cowen
CHF187.62CHF211.78
Buy
Assigned
07/27/26
Analysts Offer Insights on Healthcare Companies: Tenet Healthcare (NYSE: THC) and Dexcom (NASDAQ: DXCM)
RBC Capital Analyst forecast on CH:THC1
RBC Capital
RBC Capital
CHF190.04CHF227.88
Buy
Reiterated
07/26/26
Analysts Offer Insights on Healthcare Companies: Tenet Healthcare (NYSE: THC), Legend Biotech (NASDAQ: LEGN) and Vertex Pharmaceuticals (NASDAQ: VRTX)
Barclays
CHF193.26CHF218.22
Buy
Reiterated
07/24/26
Barclays Sticks to Its Buy Rating for Tenet Healthcare (THC)
Cantor Fitzgerald Analyst forecast on CH:THC1
Cantor Fitzgerald
Cantor Fitzgerald
CHF197.29
Buy
Reiterated
07/23/26
Tenet Healthcare (THC) Receives a Buy from Cantor Fitzgerald
J.P. Morgan Analyst forecast on CH:THC1
J.P. Morgan
J.P. Morgan
CHF225.47CHF209.36
Buy
Reiterated
05/22/26
J.P. Morgan Sticks to Its Buy Rating for Tenet Healthcare (THC)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
UBS
CHF248.02
Buy
Reiterated
08/25/26
UBS Reaffirms Their Buy Rating on Tenet Healthcare (THC)
Mizuho Securities Analyst forecast on CH:THC1
Mizuho Securities
Mizuho Securities
CHF201.31CHF233.52
Buy
Reiterated
08/10/26
Tenet Healthcare price target raised to $290 from $250 at MizuhoTenet Healthcare price target raised to $290 from $250 at Mizuho
Bank of America Securities Analyst forecast on CH:THC1
Bank of America Securities
Bank of America Securities
CHF233.52CHF237.55
Buy
Reiterated
08/10/26
Bank of America Securities Sticks to Their Buy Rating for Tenet Healthcare (THC)
Wells Fargo Analyst forecast on CH:THC1
Wells Fargo
Wells Fargo
CHF186.01CHF226.27
Buy
Assigned
07/31/26
Tenet Healthcare price target raised to $281 from $231 at Wells FargoTenet Healthcare price target raised to $281 from $231 at Wells Fargo
Goldman Sachs Analyst forecast on CH:THC1
Goldman Sachs
Goldman Sachs
CHF202.92CHF245.6
Buy
Assigned
07/29/26
Tenet Healthcare price target raised to $305 from $252 at Goldman SachsTenet Healthcare price target raised to $305 from $252 at Goldman Sachs
Truist Financial Analyst forecast on CH:THC1
Truist Financial
Truist Financial
CHF217.42CHF233.52
Buy
Reiterated
07/28/26
Truist Financial Remains a Buy on Tenet Healthcare (THC)
Robert W. Baird Analyst forecast on CH:THC1
Robert W. Baird
Robert W. Baird
CHF169.1CHF225.47
Hold
Reiterated
07/28/26
Tenet Healthcare price target raised to $280 from $210 at BairdTenet Healthcare price target raised to $280 from $210 at Baird
Morgan Stanley Analyst forecast on CH:THC1
Morgan Stanley
Morgan Stanley
CHF204.53CHF220.64
Buy
Reiterated
07/27/26
Tenet Healthcare price target raised to $274 from $254 at Morgan StanleyTenet Healthcare price target raised to $274 from $254 at Morgan Stanley
Guggenheim Analyst forecast on CH:THC1
Guggenheim
Guggenheim
CHF194.87CHF227.88
Buy
Reiterated
07/27/26
Tenet Healthcare price target raised to $283 from $242 at GuggenheimTenet Healthcare price target raised to $283 from $242 at Guggenheim
Stephens
CHF201.31CHF229.49
Buy
Reiterated
07/27/26
Tenet Healthcare price target raised to $285 from $250 at StephensTenet Healthcare price target raised to $285 from $250 at Stephens
TD Cowen
CHF187.62CHF211.78
Buy
Assigned
07/27/26
Analysts Offer Insights on Healthcare Companies: Tenet Healthcare (NYSE: THC) and Dexcom (NASDAQ: DXCM)
RBC Capital Analyst forecast on CH:THC1
RBC Capital
RBC Capital
CHF190.04CHF227.88
Buy
Reiterated
07/26/26
Analysts Offer Insights on Healthcare Companies: Tenet Healthcare (NYSE: THC), Legend Biotech (NASDAQ: LEGN) and Vertex Pharmaceuticals (NASDAQ: VRTX)
Barclays
CHF193.26CHF218.22
Buy
Reiterated
07/24/26
Barclays Sticks to Its Buy Rating for Tenet Healthcare (THC)
Cantor Fitzgerald Analyst forecast on CH:THC1
Cantor Fitzgerald
Cantor Fitzgerald
CHF197.29
Buy
Reiterated
07/23/26
Tenet Healthcare (THC) Receives a Buy from Cantor Fitzgerald
J.P. Morgan Analyst forecast on CH:THC1
J.P. Morgan
J.P. Morgan
CHF225.47CHF209.36
Buy
Reiterated
05/22/26
J.P. Morgan Sticks to Its Buy Rating for Tenet Healthcare (THC)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ODTXOdyssey Therapeutics, Inc.
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
GPCRStructure Therapeutics, Inc. Sponsored ADR
AMLXAmylyx Pharmaceuticals Inc
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Tenet Healthcare

3 Months
Success Rate
20/26 ratings generated profit
77%
Average Return
+10.32%
Copying Andrew Mok CFA's trades and holding each position for 3 Months would result in 76.92% of your transactions generating a profit, with an average return of +10.32% per trade.
1 Year
David S MacdonaldTruist Financial
Success Rate
26/28 ratings generated profit
93%
Average Return
+38.16%
Copying David S Macdonald's trades and holding each position for 1 Year would result in 92.86% of your transactions generating a profit, with an average return of +38.16% per trade.
2 Years
Jason CassorlaGuggenheim
Success Rate
17/17 ratings generated profit
100%
Average Return
+92.13%
Copying Jason Cassorla's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +92.13% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

THC1 Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
0
0
0
0
0
Buy
24
16
16
32
26
Hold
0
1
1
2
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
24
17
17
34
27
In the current month, THC1 has received 26 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. THC1 average Analyst price target in the past 3 months is 227.37.
Each month's total comprises the sum of three months' worth of ratings.

THC1 Financial Forecast

THC1 Earnings Forecast

Next quarter’s earnings estimate for THC1 is CHF3.76 with a range of CHF3.24 to CHF4.06. The previous quarter’s EPS was CHF4.92. THC1 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year THC1 has Performed in-line its overall industry.
Next quarter’s earnings estimate for THC1 is CHF3.76 with a range of CHF3.24 to CHF4.06. The previous quarter’s EPS was CHF4.92. THC1 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year THC1 has Performed in-line its overall industry.

THC1 Sales Forecast

Next quarter’s sales forecast for THC1 is CHF4.42B with a range of CHF4.36B to CHF4.48B. The previous quarter’s sales results were CHF4.53B. THC1 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year THC1 has Performed in-line its overall industry.
Next quarter’s sales forecast for THC1 is CHF4.42B with a range of CHF4.36B to CHF4.48B. The previous quarter’s sales results were CHF4.53B. THC1 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year THC1 has Performed in-line its overall industry.

THC1 Stock Forecast FAQ

What is CH:THC1’s average 12-month price target, according to analysts?
Based on analyst ratings, Tenet Healthcare’s 12-month average price target is 227.37.
    What is CH:THC1’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:THC1, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Tenet Healthcare a Buy, Sell or Hold?
        Tenet Healthcare has a consensus rating of Strong Buy, which is based on 13 buy ratings, 1 hold ratings and 0 sell ratings.
          What is Tenet Healthcare’s share price target?
          The average share price target for Tenet Healthcare is 227.37. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is CHF248.02 ,and the lowest forecast is CHF197.29. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Tenet Healthcare?
            Tenet Healthcare’s analyst rating consensus is a Strong Buy. This is based on the ratings of 14 Wall Streets Analysts.
              How can I buy shares of Tenet Healthcare?
              To buy shares of CH:THC1, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.